CORRELATION OF VASCULAR ENDOTHELIAL GROWTH FACTOR WITH CHEMOKINES IN THE VITREOUS IN DIABETIC RETINOPATHY
暂无分享,去创建一个
T. Iwasaki | H. Goto | M. Takeuchi | T. Kezuka | Y. Usui | Y. Okunuki | Y. Wakabayashi | YOSHIHIRO WAKABAYASHI | YOSHIHIKO USUI | YOKO OKUNUKI | TAKESHI KEZUKA | MASARU TAKEUCHI | HIROSHI GOTO | TAKUYA IWASAKI
[1] M. Salorio,et al. C‐C CHEMOKINES IN THE VITREOUS OF PATIENTS WITH PROLIFERATIVE VITREORETINOPATHY AND PROLIFERATIVE DIABETIC RETINOPATHY , 1998, Retina.
[2] 坂本 泰二. 糖尿病黄斑症の治療はレーザー光凝固かステロイドか? : Diabetic Retinopathy Clinical Research Network 報告について , 2009 .
[3] J. Folkman,et al. Increased Vascular Endothelial Growth Factor Levels in the Vitreous of Eyes With Proliferative Diabetic Retinopathy , 1995 .
[4] K. Yamashiro,et al. VEGF164 is proinflammatory in the diabetic retina. , 2003, Investigative ophthalmology & visual science.
[5] D. Teti,et al. Vitreous polyamines spermidine, putrescine, and spermine in human proliferative disorders of the retina , 2003, The British journal of ophthalmology.
[6] M. R. Powers,et al. Increased Expression of Chemokine KC, an Interleukin-8 Homologue, in a Model of Oxygen-Induced Retinopathy , 2005, Current eye research.
[7] L. Aiello,et al. Vascular endothelial growth factor in ocular fluid of patients with diabetic retinopathy and other retinal disorders. , 1994, The New England journal of medicine.
[8] M. Matsumura,et al. Pigment epithelium-derived factor in the vitreous is low in diabetic retinopathy and high in rhegmatogenous retinal detachment. , 2001, American journal of ophthalmology.
[9] H. Hammes,et al. Loss of the antiangiogenic pigment epithelium-derived factor in patients with angiogenic eye disease. , 2001, Diabetes.
[10] H. Yamashita,et al. Vitreous levels of vascular endothelial growth factor and intercellular adhesion molecule 1 are related to diabetic macular edema. , 2005, Ophthalmology.
[11] M. Serio,et al. Cell cycle-dependent expression of CXC chemokine receptor 3 by endothelial cells mediates angiostatic activity. , 2001, The Journal of clinical investigation.
[12] S. Yoshida,et al. Role of MCP‐1 and MIP‐1α in retinal neovascularization during postischemic inflammation in a mouse model of retinal neovascularization , 2003, Journal of leukocyte biology.
[13] R. Strieter,et al. Interferon-induced protein 10 and interleukin 8. C-X-C chemokines present in proliferative diabetic retinopathy. , 1998, Archives of ophthalmology.
[14] Armen B. Shanafelt,et al. The Functional Role of the ELR Motif in CXC Chemokine-mediated Angiogenesis (*) , 1995, The Journal of Biological Chemistry.
[15] P. Campochiaro,et al. Vitreous levels of pigment epithelium-derived factor and vascular endothelial growth factor: implications for ocular angiogenesis. , 2004, American journal of ophthalmology.
[16] R. Strieter,et al. Cytokines in proliferative diabetic retinopathy and proliferative vitreoretinopathy. , 1995, Current eye research.
[17] M. Burdick,et al. CXC chemokines in angiogenesis , 2000, Journal of leukocyte biology.
[18] W. Benedict,et al. Pigment epithelium-derived factor: a potent inhibitor of angiogenesis. , 1999, Science.
[19] N. Bressler,et al. A phase II randomized clinical trial of intravitreal bevacizumab for diabetic macular edema. , 2007, Ophthalmology.
[20] Y. Tagawa,et al. Monocyte Chemotactic Protein-1 in the Vitreous of Patients with Proliferative Diabetic Retinopathy , 2001, Ophthalmologica.
[21] J. Gilbert,et al. Independent effects of complement factor H Y402H polymorphism and cigarette smoking on risk of age-related macular degeneration. , 2007, Ophthalmology.
[22] R. Strieter,et al. Interleukin-8 as a macrophage-derived mediator of angiogenesis. , 1992, Science.